Resources

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

Product: — Cochrane Library

Drug Interventions Immune System Treatments Vaccines & Immunity

www.cochranelibrary.com Last Updated: May 20, 2021

Also available in Français

The Impact of Reopening and the Lifting of COVID‑19 Restrictions

Product: — Evidence Synthesis Network

Public Health Policy Re-Opening Regulation & Policy

esnetwork.ca Last Updated: May 12, 2021

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: May 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Lay Summary

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 7, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 7, 2021

A Vaccination Strategy for Ontario COVID‑19 Hotspots and Essential Workers

Product: — Science Table

Future Planning Models Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: April 23, 2021

Fighting COVID‑19 in Ontario: The Way Forward

Product: — Science Table

About Coronavirus Epidemiology Public Health Policy Regulation & Policy

covid19-sciencetable.ca Last Updated: April 20, 2021